Table 4.
Characteristic | MSK-BFI | LARS Total | ||||
---|---|---|---|---|---|---|
Estimate | 95% CI | p value | Estimate | 95% CI | p value | |
Tumour distance from the anal verge | 0.939 | 0.305 to 1.574 | 0.004 | −0.544 | −1.019 to 0.069 | 0.025 |
Chemoradiation (yes vs no) | −1.390 | −4.705 to 1.926 | 0.411 | 1.343 | −1.14 to 3.826 | 0.289 |
Diverting loop ileostomy (yes vs no) | −2.431 | −6.769 to 1.907 | 0.272 | 0.544 | −2.705 to 3.792 | 0.743 |
Pathological AJCC stage | ||||||
0/Tis vs III | 3.095 | −1.817 to 8.007 | 0.217 | −3.108 | −6.786 to 0.571 | 0.098 |
I vs III | 4.992 | 2.918 to 0.932 | 0.016 | −2.437 | −5.477 to 0.603 | 0.116 |
II vs III | 7.897 | 2.918 to 12.876 | 0.002 | −4.4 | −8.129 to −0.672 | 0.021 |
Abbreviations: AJCC, American Joint Committee on Cancer.